Literature DB >> 23630198

MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles.

Hongqi Xin1, Yi Li, Zhongwu Liu, Xinli Wang, Xia Shang, Yisheng Cui, Zheng Gang Zhang, Michael Chopp.   

Abstract

To test, in vivo, the hypothesis that exosomes from multipotent mesenchymal stromal cells (MSCs) mediate microRNA 133b (miR-133b) transfer which promotes neurological recovery from stroke, we used knockin and knockdown technologies to upregulate or downregulate the miR-133b level in MSCs (miR-133b(+) MSCs or miR-133b(-) MSCs) and their corresponding exosomes, respectively. Rats were subjected to middle cerebral artery occlusion (MCAo) and were treated with naïve MSCs, miR-133b(+) MSCs, or miR-133b(-) MSC at 1 day after MCAo. Compared with controls, rats receiving naïve MSC treatment significantly improved functional recovery and exhibited increased axonal plasticity and neurite remodeling in the ischemic boundary zone (IBZ) at day 14 after MCAo. The outcomes were significantly enhanced with miR-133b(+) MSC treatment, and were significantly decreased with miR-133b(-) MSC treatment, compared to naïve MSC treatment. The miR-133b level in exosomes collected from the cerebral spinal fluid was significantly increased after miR-133b(+) MSC treatment, and was significantly decreased after miR-133b(-) MSC treatment at day 14 after MCAo, compared to naïve MSC treatment. Tagging exosomes with green fluorescent protein demonstrated that exosomes-enriched extracellular particles were released from MSCs and transferred to adjacent astrocytes and neurons. The expression of selective targets for miR-133b, connective tissue growth factor and ras homolog gene family member A, was significantly decreased in the IBZ after miR-133b(+) MSC treatment, while their expression remained at similar elevated levels after miR-133b(-) MSC treatment, compared to naïve MSC treatment. Collectively, our data suggest that exosomes from MSCs mediate the miR-133b transfer to astrocytes and neurons, which regulate gene expression, subsequently benefit neurite remodeling and functional recovery after stroke. © AlphaMed Press.

Entities:  

Keywords:  Exosomes; Multipotent mesenchymal stromal cells; Neurite remodeling; Stroke; microRNA 133b

Mesh:

Substances:

Year:  2013        PMID: 23630198      PMCID: PMC3788061          DOI: 10.1002/stem.1409

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  101 in total

1.  Essential roles of Drosophila RhoA in the regulation of neuroblast proliferation and dendritic but not axonal morphogenesis.

Authors:  T Lee; C Winter; S S Marticke; A Lee; L Luo
Journal:  Neuron       Date:  2000-02       Impact factor: 17.173

Review 2.  MicroRNAs in neuronal development, function and dysfunction.

Authors:  Reuben Saba; Gerhard M Schratt
Journal:  Brain Res       Date:  2010-04-07       Impact factor: 3.252

Review 3.  Flow cytometric analysis of circulating microparticles in plasma.

Authors:  Aaron F Orozco; Dorothy E Lewis
Journal:  Cytometry A       Date:  2010-06       Impact factor: 4.355

Review 4.  MicroRNA function in neuronal development, plasticity and disease.

Authors:  Roberto Fiore; Gabriele Siegel; Gerhard Schratt
Journal:  Biochim Biophys Acta       Date:  2008-01-14

5.  Global test statistics for treatment effect of stroke and traumatic brain injury in rats with administration of bone marrow stromal cells.

Authors:  Mei Lu; Jieli Chen; Dunyue Lu; Li Yi; Asim Mahmood; Michael Chopp
Journal:  J Neurosci Methods       Date:  2003-09-30       Impact factor: 2.390

Review 6.  Rho and Ras GTPases in axon growth, guidance, and branching.

Authors:  Alan Hall; Giovanna Lalli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

7.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.

Authors:  Ruenn Chai Lai; Fatih Arslan; May May Lee; Newman Siu Kwan Sze; Andre Choo; Tian Sheng Chen; Manuel Salto-Tellez; Leo Timmers; Chuen Neng Lee; Reida Menshawe El Oakley; Gerard Pasterkamp; Dominique P V de Kleijn; Sai Kiang Lim
Journal:  Stem Cell Res       Date:  2010-01-04       Impact factor: 2.020

8.  Connective tissue growth factor is expressed by a subset of reactive astrocytes in human cerebral infarction.

Authors:  J M Schwab; E Postler; T D Nguyen; M Mittelbronn; R Meyermann; H J Schluesener
Journal:  Neuropathol Appl Neurobiol       Date:  2000-10       Impact factor: 8.090

9.  MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.

Authors:  W Qin; P Dong; C Ma; K Mitchelson; T Deng; L Zhang; Y Sun; X Feng; Y Ding; X Lu; J He; H Wen; J Cheng
Journal:  Oncogene       Date:  2011-12-19       Impact factor: 9.867

10.  The cell surface proteome of human mesenchymal stromal cells.

Authors:  Christian Niehage; Charlotte Steenblock; Theresia Pursche; Martin Bornhäuser; Denis Corbeil; Bernard Hoflack
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

View more
  287 in total

1.  Defining the optimal window for cranial transplantation of human induced pluripotent stem cell-derived cells to ameliorate radiation-induced cognitive impairment.

Authors:  Munjal M Acharya; Vahan Martirosian; Lori-Ann Christie; Lara Riparip; Jan Strnadel; Vipan K Parihar; Charles L Limoli
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

Review 2.  Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics.

Authors:  Anuradha Kalani; Alka Tyagi; Neetu Tyagi
Journal:  Mol Neurobiol       Date:  2013-09-03       Impact factor: 5.590

Review 3.  Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases.

Authors:  Rutao Liu; Jing Liu; Xiaofei Ji; Yang Liu
Journal:  Metab Brain Dis       Date:  2013-12       Impact factor: 3.584

4.  Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair.

Authors:  Arash Aghajani Nargesi; Lilach O Lerman; Alfonso Eirin
Journal:  Curr Gene Ther       Date:  2017       Impact factor: 4.391

Review 5.  Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.

Authors:  Ali Hassanzadeh; Heshu Sulaiman Rahman; Alexander Markov; Judi Januadi Endjun; Angelina Olegovna Zekiy; Max Stanley Chartrand; Nasrin Beheshtkhoo; Mohammad Amin Jadidi Kouhbanani; Faroogh Marofi; Marzieh Nikoo; Mostafa Jarahian
Journal:  Stem Cell Res Ther       Date:  2021-05-21       Impact factor: 6.832

Review 6.  Exosome-mediated amplification of endogenous brain repair mechanisms and brain and systemic organ interaction in modulating neurological outcome after stroke.

Authors:  Poornima Venkat; Jieli Chen; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2018-06-11       Impact factor: 6.200

7.  The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synuclein.

Authors:  TaeHee Kim; Suresh L Mehta; Kahlilia C Morris-Blanco; Anil K Chokkalla; Bharath Chelluboina; Mary Lopez; Ruth Sullivan; Hung Tae Kim; Thomas D Cook; Joo Yong Kim; HwuiWon Kim; Chanul Kim; Raghu Vemuganti
Journal:  Sci Signal       Date:  2018-12-11       Impact factor: 8.192

8.  Mesenchymal Stem Cell-Derived Exosomes Improve Functional Recovery in Rats After Traumatic Brain Injury: A Dose-Response and Therapeutic Window Study.

Authors:  Yanlu Zhang; Yi Zhang; Michael Chopp; Zheng Gang Zhang; Asim Mahmood; Ye Xiong
Journal:  Neurorehabil Neural Repair       Date:  2020-05-28       Impact factor: 3.919

Review 9.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

10.  Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration.

Authors:  Meadhbh Á Brennan; Pierre Layrolle; David J Mooney
Journal:  Adv Funct Mater       Date:  2020-03-11       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.